The information collected from our customers and stakeholders will help ensure that users have an effective, efficient, and satisfying experience with FDA's programs. This feedback will provide insights into customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. These collections will allow for ongoing, collaborative and actionable communications between FDA and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management.
The latest form for Qualitative Feedback on Food and Drug Administration Service Delivery expires 2023-12-31 and can be found here.
Document Name |
---|
Supplementary Document |
Supplementary Document |
Justification for No Material/Nonsubstantive Change |
Supporting Statement B |
Supporting Statement A |
Approved without change |
Extension without change of a currently approved collection | 2023-11-28 | |
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2022-06-30 | |
Approved without change |
Extension without change of a currently approved collection | 2020-11-27 | |
Approved without change |
Revision of a currently approved collection | 2017-11-01 | |
Approved without change |
No material or nonsubstantive change to a currently approved collection | 2015-07-22 | |
Approved without change |
Extension without change of a currently approved collection | 2014-09-24 | |
Approved without change |
New collection (Request for a new OMB Control Number) | 2011-05-26 |
Federal Enterprise Architecture: Health - Health Care Services